6533b7d7fe1ef96bd126845f

RESEARCH PRODUCT

Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries.

Juan B. SalomAlfredo PeralesJoséa. AlabadíTeresa JoverGermán TorregrosaFrancisco J. MirandaEnrique Alborch

subject

AdultMaleSerotoninNicardipineCerebral arteriesProstaglandinPharmacologyIn Vitro TechniquesDinoprostchemistry.chemical_compoundNicardipineCerebral vasospasmmedicine.arterymedicineHumansMagnesiumNimodipineAgedPharmacologyAged 80 and overChemistryCerebral ArteriesMiddle AgedEGTAIschemic Attack TransientVasoconstrictionAnesthesiaMiddle cerebral arteryCirculatory systemCalciumFemaleNimodipinemedicine.drug

description

The isometric tension recorded from ring segments of branches of human middle cerebral artery was the parameter used to study the inhibition of spasmogen-induced contractions as model for cerebral vasospasm. Concentration-response curves to 5-hydroxytryptamine (10(-9)-3 x 10(-5) M) and prostaglandin F2 alpha (10(-7)-3 x 10(-5) M) were inhibited in Ca(2+)-free medium and in Ca(2+)-free medium to which EGTA (1 mM) had been added, respectively. Nimodipine (10(-7), 10(-5) M), nicardipine (10(-7), 10(-5) M) and Mg2+ (magnesium sulfate 10(-4), 10(-2) M) inhibited the 5-HT-elicited contractions, and this inhibition was similar for the highest concentrations tested. In contrast, nimodipine and nicardipine were more effective than Mg2+ to inhibit the prostaglandin F2 alpha-elicited contractions. Nimodipine (10(-9)-10(-5) M), nicardipine (10(-9)-10(-5) M) and Mg2+ (10(-5)-3 x 10(-2) M) relaxed the arteries precontracted with PGF2 alpha (10(-5) M), but nicardipine was the most potent relaxant drug. Because 5-hydroxytryptamine and prostaglandin F2 alpha may be involved in the pathogenesis of cerebral vasospasm, nimodipine, nicardipine, and Mg2+ could be used in the pharmacological treatment of this disorder. However, dihydropyridines (particularly nicardipine) are more potent anticonstrictors than Mg2+.

10.1016/0014-2999(92)90289-ghttps://pubmed.ncbi.nlm.nih.gov/1473564